Morphine is widely considered the "gold-standard treatment" for pain during cancer care, but a new study found the drug was not superior to other opiates.
Author: Paige Twenter
Welireg (belzutifan), a Merck drug co-developed by researchers at Dallas-based UT Southwestern Medical Center, gained a new approval Dec. 14.
Researchers at New York City's Weill Cornell Medicine and Hospital for Special Surgery uncovered why cancer cells spread to the spine three to five times more than other bones, The Washington Post reported Nov. 28.
The FDA approved GSK's Jemperli (dostarlimab) in combination with carboplatin and paclitaxel for adults with primary advanced or recurrent endometrial cancer who are mismatch repair deficient or microsatellite instability-high.